Report Detail
(Post-pandemic Era)-Global Cell-Free DNA (cfDNA) Testing Market Segment Research Report 2022
- RnM4477066 |
- 04 August, 2022 |
- Global |
- 117 Pages |
- XYZResearch |
- Medical Devices & Consumables
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Beijing Yanjing Bizhi Information Consulting Co., Ltd. （XYZResearch）released the 《(Post-pandemic Era)-Global Cell-Free DNA (cfDNA) Testing Market Segment Research Report 2022》, which aims to sort out the development status and trends of the Cell-Free DNA (cfDNA) Testing industry at home and abroad, estimate the overall market scale of the Cell-Free DNA (cfDNA) Testing industry and the market share of major countries, Cell-Free DNA (cfDNA) Testing industry, and study and judge the downstream market demand of Cell-Free DNA (cfDNA) Testing through systematic research, Analyze the competition pattern of Cell-Free DNA (cfDNA) Testing, so as to help solve the pain points of various stakeholders in Cell-Free DNA (cfDNA) Testing industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Cell-Free DNA (cfDNA) Testing Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Cell-Free DNA (cfDNA) Testing Market?
Agilent Technology
Allenex
Biocept
Biodesix
CareDx
Guardant Health
Illumania
Invited
Natera
Quest Diagnostics
Roche Holdings
Sequenom
Trovagene
Major Type of Cell-Free DNA (cfDNA) Testing Covered in XYZResearch report:
Donor-Derived Cell-Free DNA (DdcfDNA)
Circulating Cell-Free Tumor DNA (CtDNA)
Cell-Free Fetal DNA (NIPT)
Application Segments Covered in XYZResearch Market
Hospital
Ambulatory Surgical Centers
Cancer Research Institutes
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Cell-Free DNA (cfDNA) Testing Market Segment Research Report 2022
1. Research Scope
2. Market Overview
- 2.1 Product Introduction, Application, Picture
- 2.2 Global Cell-Free DNA (cfDNA) Testing Market by Value
- 2.2.1 Global Cell-Free DNA (cfDNA) Testing Revenue by Type
- 2.2.2 Global Cell-Free DNA (cfDNA) Testing Market by Value (%)
- 2.3 Global Cell-Free DNA (cfDNA) Testing Market by Production
- 2.3.1 Global Cell-Free DNA (cfDNA) Testing Production by Type
- 2.3.2 Global Cell-Free DNA (cfDNA) Testing Market by Production (%)
3. The Major Driver of Cell-Free DNA (cfDNA) Testing Industry
- 3.1 Historical & Forecast Global Cell-Free DNA (cfDNA) Testing Demand
- 3.2 Largest Application for Cell-Free DNA (cfDNA) Testing (2018-2028)
- 3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Cell-Free DNA (cfDNA) Testing Market
- 4.1 Regional Market Size in Terms of Production & Demand (2022)
- 4.2 Regional Market Share in Terms of Revenue (2018-2022)
- 4.3 Concentration Ratio (CR5& CR10) of Cell-Free DNA (cfDNA) Testing Market
- 4.4 Mergers & Acquisitions, Expansion Plans
5. US Cell-Free DNA (cfDNA) Testing Production, Demand (2018-2028)
- 5.1 Current and Estimated Production Breakdown by Type
- 5.2 Current and Estimated Demand Breakdown by Type
- 5.3 Current and Estimated Demand Breakdown by Application
- 5.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 5.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Cell-Free DNA (cfDNA) Testing Production, Demand (2018-2028)
- 6.1 Current and Estimated Production Breakdown by Type
- 6.2 Current and Estimated Demand Breakdown by Type
- 6.3 Current and Estimated Demand Breakdown by Application
- 6.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 6.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Cell-Free DNA (cfDNA) Testing Production, Demand (2018-2028)
- 7.1 Current and Estimated Production Breakdown by Type
- 7.2 Current and Estimated Demand Breakdown by Type
- 7.3 Current and Estimated Demand Breakdown by Application
- 7.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 7.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Cell-Free DNA (cfDNA) Testing Production, Demand (2018-2028)
- 8.1 Current and Estimated Production Breakdown by Type
- 8.2 Current and Estimated Demand Breakdown by Type
- 8.3 Current and Estimated Demand Breakdown by Application
- 8.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 8.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Cell-Free DNA (cfDNA) Testing Production, Demand (2018-2028)
- 9.1 Current and Estimated Production Breakdown by Type
- 9.2 Current and Estimated Demand Breakdown by Type
- 9.3 Current and Estimated Demand Breakdown by Application
- 9.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 9.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Cell-Free DNA (cfDNA) Testing Production, Demand (2018-2028)
- 10.1 Current and Estimated Production Breakdown by Type
- 10.2 Current and Estimated Demand Breakdown by Type
- 10.3 Current and Estimated Demand Breakdown by Application
- 10.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 10.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Cell-Free DNA (cfDNA) Testing Production, Demand (2018-2028)
- 11.1 Current and Estimated Production Breakdown by Type
- 11.2 Current and Estimated Demand Breakdown by Type
- 11.3 Current and Estimated Demand Breakdown by Application
- 11.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 11.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. Global Cell-Free DNA (cfDNA) Testing Average Price Trend
- 12.1 Market Price for Each Type of Cell-Free DNA (cfDNA) Testing in US (2018-2022)
- 12.2 Market Price for Each Type of Cell-Free DNA (cfDNA) Testing in Europe (2018-2022)
- 12.3 Market Price for Each Type of Cell-Free DNA (cfDNA) Testing in China (2018-2022)
- 12.4 Market Price for Each Type of Cell-Free DNA (cfDNA) Testing in Japan (2018-2022)
- 12.5 Market Price for Each Type of Cell-Free DNA (cfDNA) Testing in India (2018-2022)
- 12.6 Market Price for Each Type of Cell-Free DNA (cfDNA) Testing in Korea (2018-2022)
- 12.7 Market Price for Each Type of Cell-Free DNA (cfDNA) Testing in Southeast Asia (2018-2022)
13. Industrial Chain (Impact of COVID-19)
- 13.1 Cell-Free DNA (cfDNA) Testing Industrial Chain Analysis
- 13.2 Downstream
- 13.3 Impact of COVID-19
- 13.4 Post-pandemic Era
- 13.5 Technology Trends of Cell-Free DNA (cfDNA) Testing
14. Cell-Free DNA (cfDNA) Testing Competitive Landscape
- 14.1 Agilent Technology
- 14.1.1 Agilent Technology Company Profiles
- 14.1.2 Agilent Technology Product Introduction
- 14.1.3 Agilent Technology Cell-Free DNA (cfDNA) Testing Sales, Revenue (2018-2022)
- 14.1.4 Strategic initiatives
- 14.2 Allenex
- 14.2.1 Allenex Company Profiles
- 14.2.2 Allenex Product Introduction
- 14.2.3 Allenex Cell-Free DNA (cfDNA) Testing Sales, Revenue (2018-2022)
- 14.2.4 Strategic initiatives
- 14.3 Biocept
- 14.3.1 Biocept Company Profiles
- 14.3.2 Biocept Product Introduction
- 14.3.3 Biocept Cell-Free DNA (cfDNA) Testing Sales, Revenue (2018-2022)
- 14.3.4 Strategic initiatives
- 14.4 Biodesix
- 14.4.1 Biodesix Company Profiles
- 14.4.2 Biodesix Product Introduction
- 14.4.3 Biodesix Cell-Free DNA (cfDNA) Testing Sales, Revenue (2018-2022)
- 14.4.4 Strategic initiatives
- 14.5 CareDx
- 14.5.1 CareDx Company Profiles
- 14.5.2 CareDx Product Introduction
- 14.5.3 CareDx Cell-Free DNA (cfDNA) Testing Sales, Revenue (2018-2022)
- 14.5.4 Strategic initiatives
- 14.6 Guardant Health
- 14.6.1 Guardant Health Company Profiles
- 14.6.2 Guardant Health Product Introduction
- 14.6.3 Guardant Health Cell-Free DNA (cfDNA) Testing Sales, Revenue (2018-2022)
- 14.6.4 Strategic initiatives
- 14.7 Illumania
- 14.7.1 Illumania Company Profiles
- 14.7.2 Illumania Product Introduction
- 14.7.3 Illumania Cell-Free DNA (cfDNA) Testing Sales, Revenue (2018-2022)
- 14.7.4 Strategic initiatives
- 14.8 Invited
- 14.8.1 Invited Company Profiles
- 14.8.2 Invited Product Introduction
- 14.8.3 Invited Cell-Free DNA (cfDNA) Testing Sales, Revenue (2018-2022)
- 14.8.4 Strategic initiatives
- 14.9 Natera
- 14.9.1 Natera Company Profiles
- 14.9.2 Natera Product Introduction
- 14.9.3 Natera Cell-Free DNA (cfDNA) Testing Sales, Revenue (2018-2022)
- 14.9.4 Strategic initiatives
- 14.10 Quest Diagnostics
- 14.10.1 Quest Diagnostics Company Profiles
- 14.10.2 Quest Diagnostics Product Introduction
- 14.10.3 Quest Diagnostics Cell-Free DNA (cfDNA) Testing Sales, Revenue (2018-2022)
- 14.10.4 Strategic initiatives
- 14.11 Roche Holdings
- 14.12 Sequenom
- 14.13 Trovagene
15. Conclusion
16. Methodology and Data Source
Summary:
Get latest Market Research Reports on Cell-Free DNA (cfDNA) Testing. Industry analysis & Market Report on Cell-Free DNA (cfDNA) Testing is a syndicated market report, published as (Post-pandemic Era)-Global Cell-Free DNA (cfDNA) Testing Market Segment Research Report 2022. It is complete Research Study and Industry Analysis of Cell-Free DNA (cfDNA) Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
